- Pharmaceutical companies
- Curium
Curium
Phone: +358 14 334 5211
E-mail: orders.finland@curiumpharma.com
Web: https://www.curiumfinland.fi/
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products to customers around the globe. Drawing on years of proven experience, we aim to drive the nuclear medicine industry forward through excellence, reliability and unparalleled service. We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. Curium specialises in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment, and proven patient outcomes.
For detailed contact information visit location pages below.
Curium's locations around the world
Clinical Trials sponsored by Curium
-
Curium US LLCAktiv, ikke rekrutterendeMetastase fra ondartet svulst i prostataForente stater, Frankrike, Spania, Italia
-
Curium US LLCRekrutteringProstatakreft | Prostata adenokarsinomForente stater
-
Curium US LLCFullførtProstatakreft | Prostata adenokarsinom | Biokjemisk tilbakefall av ondartet neoplasma i prostataForente stater
-
Curium US LLCFullførtMetastase fra ondartet svulst i prostata (lidelse)Forente stater
-
Curium PET FranceAktiv, ikke rekrutterendeProstatakreft TilbakevendendeFrankrike
-
Curium US LLCGodkjent for markedsføringNevroendokrine svulster
-
Weill Medical College of Cornell UniversityCurium US LLCRekrutteringMeningiomaForente stater
-
Veerle RuijtersZonMw: The Netherlands Organisation for Health Research and Development; Curium PET FranceHar ikke rekruttert ennåGlioblastom | Radionekrose av hjernenNederland